DrugPatentWatch Database Preview
Profile for United States of America Patent: 2003114390
US Patent Family Members and Approved Drugs for United States of America Patent: 2003114390
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 4, 2020 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Try a Free Trial | Oct 4, 2020 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Try a Free Trial | Oct 4, 2020 | Astrazeneca Ab | XIGDUO XR | dapagliflozin; metformin hydrochloride |
➤ Try a Free Trial | Oct 4, 2020 | Astrazeneca Ab | FARXIGA | dapagliflozin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |